Anti-synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

被引：0
|
作者：
Yoshifuji, H
Fujii, T
Kobayashi, S
Umehara, H
Fujita, Y
Kawabata, D
Tanaka, M
Mimori, T
机构：
[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[2] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan
[3] Natl Utano Hosp, Kyoto, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：S311 / S312
页数：2
相关论文
共 50 条
  • [31] INTERSTITIAL LUNG DISEASE IN INFLAMMATORY MYOPATHIES: CLINICAL AND IMMUNOSEROLOGICAL CHARACTERISTICS
    Leal Castro, S.
    Gomez, R.
    Perrotta, N.
    Pino, M. S.
    Laborde, H.
    Dubinsky, D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S169 - S169
  • [32] Interstitial Lung Disease in Inflammatory Myopathies: Clinical Phenotypes and Prognosis
    Kiely, Patrick D. W.
    Chua, Felix
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (09)
  • [33] Anti-SSa/SSb and Ro52 and Interstitial Lung Disease in Idiopathic Inflammatory Myopathies
    Narain, Sonali
    Valle, Ana
    Barilla-Labarca, Maria-Louise
    Marder, Galina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1429 - 1431
  • [34] Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series
    Giannini, Margherita
    Notarnicola, Antonella
    Dastmalchi, Maryam
    Lundberg, Ingrid E.
    Lopalco, Giuseppe
    Iannone, Florenzo
    CLINICAL RHEUMATOLOGY, 2016, 35 (09) : 2363 - 2367
  • [35] Use of Tacrolimus to Treat Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
    Warrior, K.
    Bemiss, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
    Sodsri, Tulaton
    Petnak, Tananchai
    Ngamjanyaporn, Pintip
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [37] Successful baricitinib treatment of refractory anti-synthetase syndrome associated with interstitial lung disease
    Sugino, Keishi
    Ono, Hirotaka
    Saito, Mikako
    Ando, Masahiro
    Tsuboi, Eiyasu
    RESPIROLOGY CASE REPORTS, 2023, 11 (04):
  • [38] Diffuse interstitial lung disease revealing anti-synthetase syndrome: about two cases
    El Bouardi, Nizar
    Alaoui, Amina
    Haloua, Meriem
    Lamrani, Youssef
    Boubbou, Meryem
    Maaroufi, Mustapha
    Alami, Baderdine
    PAN AFRICAN MEDICAL JOURNAL, 2019, 32
  • [39] Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome
    Hui Liu
    Sheng Xie
    Tian Liang
    Li Ma
    Hongliang Sun
    Huaping Dai
    Chen Wang
    European Radiology, 2019, 29 : 5349 - 5357
  • [40] ANTI-SSA AND ANTI-JO1 LEVELS IN INTERSTITIAL LUNG DISEASE RELATED TO IDIOPATHIC INFLAMMATORY MYOPATHIES
    Giannini, M.
    Tampoia, M.
    Abbracciavento, L.
    Girolamo, F.
    Lia, A.
    Mascolo, E.
    D'Abbicco, D.
    Coladonato, L.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1282 - 1282
12345